Search tips
Search criteria 


Logo of tobcontTobacco ControlVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Tob Control. 2002 December; 11(4): 305–314.
PMCID: PMC1747685

Tobacco industry success in preventing regulation of secondhand smoke in Latin America: the "Latin Project"


Objective: To examine the tobacco industry's strategy to avoid regulations on secondhand smoke exposure in Latin America.

Methods: Systematic search of tobacco industry documents available through the internet. All available materials, including confidential reports regarding research, lobbying, and internal memoranda exchanged between the tobacco industry representatives, tobacco industry lawyers, and key players in Latin America.

Results: In Latin America, Philip Morris International and British American Tobacco, working through the law firm Covington & Burling, developed a network of well placed physicians and scientists through their "Latin Project" to generate scientific arguments minimising secondhand smoke as a health hazard, produce low estimates of exposure, and to lobby against smoke-free workplaces and public places. The tobacco industry's role was not disclosed.

Conclusions: The strategies used by the industry have been successful in hindering development of public health programmes on secondhand smoke. Latin American health professionals need to be aware of this industry involvement and must take steps to counter it to halt the tobacco epidemic in Latin America.

Full Text

The Full Text of this article is available as a PDF (168K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Glantz SA. Back to basics: getting smoke-free workplaces back on track. Tob Control. 1997 Autumn;6(3):164–166. [PMC free article] [PubMed]
  • Chapman S, Borland R, Hill D, Owen N, Woodward S. Why the tobacco industry fears the passive smoking issue. Int J Health Serv. 1990;20(3):417–427. [PubMed]
  • Fichtenberg Caroline M, Glantz Stanton A. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002 Jul 27;325(7357):188–188. [PMC free article] [PubMed]
  • Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000 Dec 14;343(24):1772–1777. [PubMed]
  • Drope J, Chapman S. Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents. J Epidemiol Community Health. 2001 Aug;55(8):588–594. [PMC free article] [PubMed]
  • Ong EK, Glantz SA. Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. Am J Public Health. 2001 Nov;91(11):1749–1757. [PubMed]
  • Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):241–247. [PubMed]
  • Ong EK, Glantz SA. Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study. Lancet. 2000 Apr 8;355(9211):1253–1259. [PubMed]
  • Barnes DE, Hanauer P, Slade J, Bero LA, Glantz SA. Environmental tobacco smoke. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):248–253. [PubMed]
  • Muggli ME, Forster JL, Hurt RD, Repace JL. The smoke you don't see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies. Am J Public Health. 2001 Sep;91(9):1419–1423. [PubMed]
  • Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23;271(8):612–617. [PubMed]
  • Kennedy GE, Bero LA. Print media coverage of research on passive smoking. Tob Control. 1999 Autumn;8(3):254–260. [PMC free article] [PubMed]
  • Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996 Fall;21(3):515–542. [PubMed]
  • Gil L, Adonis M, Cáceres D, Moreno G. Influencia de la contaminación atmosférica en la calidad de aire de interiores. El caso del centro de Santiago (Chile). Rev Med Chil. 1995 Apr;123(4):411–425. [PubMed]
  • Adonis M, Gil L. Polycyclic aromatic hydrocarbon levels and mutagenicity of inhalable particulate matter in Santiago, Chile. Inhal Toxicol. 2000 Dec;12(12):1173–1183. [PubMed]
  • Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation. 1991 Jan;83(1):1–12. [PubMed]
  • Taylor AE, Johnson DC, Kazemi H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation. 1992 Aug;86(2):699–702. [PubMed]
  • Warner KE. Tobacco industry scientific advisors: serving society or selling cigarettes? Am J Public Health. 1991 Jul;81(7):839–842. [PubMed]
  • Rennie D. Smoke and letters. JAMA. 1993 Oct 13;270(14):1742–1743. [PubMed]
  • Boffetta P, Agudo A, Ahrens W, Benhamou E, Benhamou S, Darby SC, Ferro G, Fortes C, Gonzalez CA, Jöckel KH, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst. 1998 Oct 7;90(19):1440–1450. [PubMed]
  • Hirschhorn N, Bialous SA. Second hand smoke and risk assessment: what was in it for the tobacco industry? Tob Control. 2001 Dec;10(4):375–382. [PMC free article] [PubMed]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group